Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Peeters

Showing results (361-370 of 409) with videos related to

Pageof 41
Sort By:
European Journal of Cancer (Oxford, England : 1990)|April 18, 2024
Oncological outcomes after a pathological complete response following total neoadjuvant therapy or chemoradiotherapy for high-risk locally advanced rectal cancer in the RAPIDO trialWouter H Zwart, Sofieke J D Temmink, Geke A P Hospers, et al.
European Journal of Human Genetics : EJHG|June 16, 2019
De novo variants in CNOT3 cause a variable neurodevelopmental disorderR Martin, M Splitt, D Genevieve, et al.
Arthritis and Rheumatism|January 1, 2009
Patient-reported outcomes in a randomized trial comparing four different treatment strategies in recent-onset rheumatoid arthritisS M van der Kooij, J K de Vries-Bouwstra, Y P M Goekoop-Ruiterman, et al.
Techniques in Coloproctology|November 23, 2025
Oncological outcomes of planned and unplanned low Hartmann's procedure and restorative low anterior resection for rectal cancer: a population-based cross-sectional studyE G M van Geffen, F S Verheij, S M J A Hazen, et al.
Genome Medicine|January 1, 2020
Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4Jitske van den Bulk, Els M E Verdegaal, Dina Ruano, et al.
Annals of the Rheumatic Diseases|May 20, 2009
Survival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritisLilian H D van Tuyl, Maarten Boers, Willem F Lems, et al.
The British Journal of Surgery|March 27, 2023
Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD)Sofieke J D Temmink, Koen C M J Peeters, Renu R Bahadoer, et al.
Clinical Genetics|May 31, 2008
Variable phenotypes associated with 10q23 microdeletions involving the PTEN and BMPR1A genesF H Menko, C M F Kneepkens, N de Leeuw, et al.
United European Gastroenterology Journal|July 20, 2024
T1 colorectal cancer patients' perspective on information provision and therapeutic decision-making after local resectionNik Dekkers, Hao Dang, Manon de Graaf, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 28, 2020
Importance of patient reported and clinical outcomes for patients with locally advanced rectal cancer and their treating physicians. Do clinicians know what patients want?Maxime J M van der Valk, Marit E van der Sande, Renee E Toebes, et al.
Pageof 41

Showing results (361-370 of 409) with videos related to

Sort By:
Pageof 41
European Journal of Cancer (Oxford, England : 1990)|April 18, 2024
Oncological outcomes after a pathological complete response following total neoadjuvant therapy or chemoradiotherapy for high-risk locally advanced rectal cancer in the RAPIDO trialWouter H Zwart, Sofieke J D Temmink, Geke A P Hospers, et al.
European Journal of Human Genetics : EJHG|June 16, 2019
De novo variants in CNOT3 cause a variable neurodevelopmental disorderR Martin, M Splitt, D Genevieve, et al.
Arthritis and Rheumatism|January 1, 2009
Patient-reported outcomes in a randomized trial comparing four different treatment strategies in recent-onset rheumatoid arthritisS M van der Kooij, J K de Vries-Bouwstra, Y P M Goekoop-Ruiterman, et al.
Techniques in Coloproctology|November 23, 2025
Oncological outcomes of planned and unplanned low Hartmann's procedure and restorative low anterior resection for rectal cancer: a population-based cross-sectional studyE G M van Geffen, F S Verheij, S M J A Hazen, et al.
Genome Medicine|January 1, 2020
Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4Jitske van den Bulk, Els M E Verdegaal, Dina Ruano, et al.
Annals of the Rheumatic Diseases|May 20, 2009
Survival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritisLilian H D van Tuyl, Maarten Boers, Willem F Lems, et al.
The British Journal of Surgery|March 27, 2023
Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD)Sofieke J D Temmink, Koen C M J Peeters, Renu R Bahadoer, et al.
Clinical Genetics|May 31, 2008
Variable phenotypes associated with 10q23 microdeletions involving the PTEN and BMPR1A genesF H Menko, C M F Kneepkens, N de Leeuw, et al.
United European Gastroenterology Journal|July 20, 2024
T1 colorectal cancer patients' perspective on information provision and therapeutic decision-making after local resectionNik Dekkers, Hao Dang, Manon de Graaf, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 28, 2020
Importance of patient reported and clinical outcomes for patients with locally advanced rectal cancer and their treating physicians. Do clinicians know what patients want?Maxime J M van der Valk, Marit E van der Sande, Renee E Toebes, et al.
Pageof 41